What is it about?
Complements related disease
Featured Image
Photo by Skyler H on Unsplash
Why is it important?
High prevalence of mutation associated atypical HUS
Perspectives
First published cohort in the middle east about children with atypical HUS
Abdulaziz Bamhraz
McMaster University
Read the Original
This page is a summary of: Improved Renal Recovery with Eculizumab Therapy among Children with High Prevalence of Mutation-Associated Atypical Hemolytic Uremic Syndrome: A Retrospective Cohort Study, Kidney and Blood Pressure Research, November 2020, Karger Publishers,
DOI: 10.1159/000510612.
You can read the full text:
Contributors
The following have contributed to this page
